0534 GMT - Thomson Medical Group appears to be expanding multi-disciplinary services in Singapore and Malaysia, Maybank Research's Eric Ong says in a research report. In Singapore, the company aims to further expand its network of clinics and hospital facilities, launch a second fertility centre, and strengthen insurance partnerships, the analyst notes. In Malaysia, Thomson Hospital Kota Damansara has broadened its specialties, while Thomson Fertility has been rebranded as a leading center in reproductive medicine. The brokerage maintains the stock's hold rating, but raises the target price to S$0.062 from S$0.047 to reflect the underlying values of the healthcare services provider's land bank in Johor, Malaysia. Shares are 3.2% lower at S$0.06. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
February 12, 2026 00:34 ET (05:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.